FEMA5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
No edit summary
No edit summary
 
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
__TOC__
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
Line 18: Line 19:
!'''Notes'''
!'''Notes'''
|-
|-
|CHAPTER 2 (TUMOURS OF THE OVARY)
|
==== CHAPTER 2 (TUMOURS OF THE OVARY) ====
|
|
----
----
Line 808: Line 810:
|
|
|-
|-
|CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS)
|
==== CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) ====
|
|
----
----
Line 839: Line 842:
|
|
|-
|-
|CHAPTER 4 (TUMOURS OF THE PERITONEUM)
|
==== CHAPTER 4 (TUMOURS OF THE PERITONEUM) ====
|
|
----
----
Line 1,123: Line 1,127:
|
|
|-
|-
|CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE)
|
==== CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) ====
|
|
----
----
Line 1,297: Line 1,302:
|
|
|-
|-
|CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS)
|
==== CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) ====
|
|
----
----
Line 1,405: Line 1,411:
|
|
|-
|-
|CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS)
|
==== CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) ====
|
|
----
----
Line 1,744: Line 1,751:
|
|
|-
|-
|CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE)
|
==== CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) ====
|
|
----
----
Line 1,874: Line 1,882:
|
|
|-
|-
|CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX)
|
==== CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) ====
|
|
----
----
Line 2,235: Line 2,244:
|
|
|-
|-
|CHAPTER 10 (TUMOURS OF THE VAGINA)
|
==== CHAPTER 10 (TUMOURS OF THE VAGINA) ====
|
|
----
----
Line 2,508: Line 2,518:
|
|
|-
|-
|CHAPTER 11 (TUMOURS OF THE VULVA)
|
==== CHAPTER 11 (TUMOURS OF THE VULVA) ====
|
|
----
----
Line 2,737: Line 2,748:
|
|
|-
|-
|CHAPTER 12 (NEUROENDOCRINE NEOPLASIA)
|
==== CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) ====
|
|
----
----
Line 2,801: Line 2,813:
|
|
|-
|-
|CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA)
|
==== CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ====
|
|
----
----
Line 2,887: Line 2,900:
|
|
|-
|-
|CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT)
|
==== CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) ====
|
|
----
----
Line 3,204: Line 3,218:
|
|
|-
|-
|CHAPTER 15 (MELANOCYTIC LESIONS)
|
==== CHAPTER 15 (MELANOCYTIC LESIONS) ====
|
|
----
----
Line 3,290: Line 3,305:
|
|
|-
|-
|CHAPTER 16 (METASTASIS)
|
==== CHAPTER 16 (METASTASIS) ====
|
|
----
----
Line 3,321: Line 3,337:
|
|
|-
|-
|CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT)
|
==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) ====
|
|
----
----